Viking Global Investors’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126M | Hold |
6,978,534
| – | – | 0.37% | 67 |
|
|
2025
Q1 | $143M | Hold |
6,978,534
| – | – | 0.45% | 61 |
|
|
2024
Q4 | $179M | Sell |
6,978,534
-1,046,031
| -13% | -$26.9M | 0.58% | 48 |
|
|
2024
Q3 | $133M | Hold |
8,024,565
| – | – | 0.49% | 55 |
|
|
2024
Q2 | $154M | Hold |
8,024,565
| – | – | 0.59% | 41 |
|
|
2024
Q1 | $190M | Hold |
8,024,565
| – | – | 0.71% | 38 |
|
|
2023
Q4 | $89.6M | Hold |
8,024,565
| – | – | 0.33% | 59 |
|
|
2023
Q3 | $74.2M | Buy |
8,024,565
+1,500,000
| +23% | +$13.9M | 0.3% | 53 |
|
|
2023
Q2 | $77.6M | Buy |
6,524,565
+2,608,695
| +67% | +$31M | 0.32% | 63 |
|
|
2023
Q1 | $52.6M | Buy |
3,915,870
+162,042
| +4% | +$2.18M | 0.25% | 62 |
|
|
2022
Q4 | $39.5M | Buy |
+3,753,828
| New | +$39.5M | 0.2% | 64 |
|